How to Help Your Patients Find Aklief in Stock: A Provider's Guide

You prescribed Aklief (Trifarotene) because it's the right treatment for your patient's acne. But a prescription that can't be filled doesn't help anyone. In 2026, providers across the country report that patients frequently call back saying their pharmacy doesn't have Aklief in stock — or that the cost is prohibitive.

This guide gives you a practical, step-by-step framework for helping your patients navigate Aklief availability and cost challenges so they can actually start treatment.

Current Availability Landscape

Aklief is not in an FDA-listed drug shortage. Galderma Laboratories continues to produce and distribute Aklief Cream 0.005% (45g airless pump) without interruption. The availability problem is at the pharmacy level:

• Chain pharmacies: Many CVS, Walgreens, and Rite Aid locations don't routinely stock Aklief due to its high wholesale cost and limited insurance coverage
• Independent pharmacies: Stocking varies; pharmacies near dermatology practices are more likely to carry it
• Mail-order pharmacies: Generally available but may require additional insurance verification
• Specialty pharmacies: Most reliable for Aklief but less convenient for patients

The retail price ranges from $760 to over $1,000 for a 45g pump, making it one of the highest-cost topical acne treatments on the market.

Why Patients Can't Find Aklief

Understanding the barriers helps you anticipate and address them proactively:

Cost Barrier

The retail price of $760 to $1,080 creates sticker shock for patients and reluctance from pharmacies. Even patients with commercial insurance often face high copays if Aklief is on a non-preferred or specialty tier.

Insurance Barrier

Most Medicare plans do not cover Aklief. Commercial plans that do cover it frequently require prior authorization and step therapy (documented failure of Tretinoin or Adapalene). This adds administrative burden and delays treatment initiation.

Stocking Barrier

With no generic available and limited demand, many pharmacies don't keep Aklief in inventory. Patients may visit their usual pharmacy only to be told it's not in stock and will need to be ordered — a process that can take 1 to 3 business days.

Awareness Barrier

Many patients don't know about manufacturer savings programs, pharmacy alternatives, or tools that can help them locate the medication. Without guidance, they may simply give up.

What Providers Can Do: 5 Actionable Steps

Step 1: Enroll Patients in the Galderma CareConnect Program Before They Leave

The single most impactful thing you can do is help patients enroll in the Galderma CareConnect Patient Savings Card before they leave your office. This dramatically changes the cost equation:

• Commercially insured patients: Pay as low as $20 per 45g pump
• Cash-paying / uninsured patients: Pay no more than $90 per 45g pump
• Valid for up to 15 fills per calendar year

Patients can enroll at aklief.com/savings or call 855-280-0543. Consider having enrollment information or QR codes available in your exam rooms.

Important: The savings card is not available for patients on government-sponsored insurance (Medicare, Medicaid, Tricare, VA benefits).

Step 2: Direct Patients to Medfinder

Instead of sending patients out to call multiple pharmacies, direct them to Medfinder. This tool allows patients (and your staff) to:

• Search for pharmacies near a zip code that have Aklief in stock
• Compare availability at chain and independent pharmacies
• Avoid the frustration of calling around and getting put on hold

You can also use medfinder.com/providers to integrate availability checking into your practice workflow.

Step 3: Send the Prescription to the Right Pharmacy

Once you or your patient identifies a pharmacy with Aklief in stock (via Medfinder or a phone call), send the electronic prescription directly to that pharmacy. This avoids the common scenario where a prescription lands at a pharmacy that doesn't have the medication, leading to delays and patient frustration.

If your patient's preferred pharmacy doesn't stock Aklief, proactively suggest an alternative before sending the prescription.

Step 4: Provide Samples When Available

If your practice has Aklief samples from Galderma, offer them to patients who are starting treatment. This accomplishes several things:

• Patients can begin treatment immediately without waiting for pharmacy logistics
• They can assess tolerability before committing to a full prescription
• It bridges the gap while insurance prior authorization is processed

Contact your Galderma representative to discuss sample availability for your practice.

Step 5: Submit Prior Authorization Proactively

Don't wait for the pharmacy to submit a PA request that gets denied. If you know the patient's plan requires prior authorization:

• Submit the PA at the time of prescribing
• Document previous retinoid trials and reasons for failure
• Include clinical rationale for Aklief specifically (e.g., truncal acne involvement, superior tolerability profile)
• Note that Aklief is the only topical retinoid with pivotal trial data for truncal acne

Galderma offers prior authorization support through their medical affairs team — contact your local representative for details.

Alternative Agents When Aklief Isn't Accessible

For patients who ultimately cannot access Aklief, have a plan B ready:

• Tretinoin (generic): $15 to $50 cash price; multiple strengths and formulations; covered by most insurance plans. First-line for many patients.
• Adapalene 0.3% (prescription): Better tolerability than Tretinoin; available as generic prescription. OTC at 0.1% strength ($10 to $30).
• Tazarotene (Tazorac, Arazlo): Most potent topical retinoid; brand-name runs $400 to $700; Arazlo lotion may offer better tolerability.
• Combination therapy: Consider Adapalene/Benzoyl Peroxide (Epiduo) for patients who need both comedolytic and antimicrobial activity.

For a patient-facing resource you can share, see alternatives to Aklief.

Workflow Tips for Your Practice

Integrating Aklief access support into your clinical workflow reduces callbacks and improves patient outcomes:

At the Point of Prescribing

1. Check insurance coverage or eligibility for the savings card
2. Enroll the patient in Galderma CareConnect (or provide instructions)
3. Use Medfinder to identify a pharmacy with stock
4. Send the prescription to the verified pharmacy
5. Provide a sample if available to start treatment immediately

Staff Training

• Train front desk and medical assistant staff on the Galderma CareConnect enrollment process
• Keep printed or digital enrollment materials in exam rooms
• Designate a staff member to handle PA submissions for Aklief and similar specialty products

Follow-Up Protocol

• Flag Aklief prescriptions for follow-up within 5 to 7 business days to confirm the patient filled their prescription
• If unfilled, investigate barriers (cost, availability, insurance) and intervene
• Document fill status in the patient chart to track access patterns

Resources for Patients

Share these articles with patients who have questions about Aklief:

• What is Aklief? Uses, dosage, and what you need to know
• Aklief side effects: What to expect and when to call your doctor
• How to save money on Aklief
• Aklief drug interactions: What to avoid

Final Thoughts

Aklief is a clinically meaningful advancement in topical acne therapy, but prescribing it is only the first step. Providers who proactively address cost, availability, and insurance barriers see better fill rates and better patient outcomes. By leveraging the Galderma CareConnect program, Medfinder, and a structured workflow, you can ensure that the medication you prescribe actually reaches your patient's skin.

For a broader overview of the Aklief supply situation, see our provider briefing on Aklief shortage: what providers need to know in 2026. For cost-saving strategies from the provider perspective, see how to help patients save money on Aklief.